Wolverine Asset Management’s Nuvation Bio NUVB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.93K | Buy |
4,069
+1,467
| +56% | +$2.86K | ﹤0.01% | 965 |
|
2025
Q1 | $4.58K | Buy |
2,602
+1,586
| +156% | +$2.79K | ﹤0.01% | 970 |
|
2024
Q4 | $2.7K | Buy |
+1,016
| New | +$2.7K | ﹤0.01% | 1034 |
|
2024
Q1 | – | Sell |
-3,904
| Closed | -$5.9K | – | 1471 |
|
2023
Q4 | $5.9K | Sell |
3,904
-2,500
| -39% | -$3.78K | ﹤0.01% | 1028 |
|
2023
Q3 | $8.58K | Hold |
6,404
| – | – | ﹤0.01% | 1099 |
|
2023
Q2 | $11.5K | Hold |
6,404
| – | – | ﹤0.01% | 1006 |
|
2023
Q1 | $10.6K | Buy |
6,404
+2,178
| +52% | +$3.62K | ﹤0.01% | 1099 |
|
2022
Q4 | $8.11K | Hold |
4,226
| – | – | ﹤0.01% | 1274 |
|
2022
Q3 | $9K | Buy |
4,226
+440
| +12% | +$937 | ﹤0.01% | 1653 |
|
2022
Q2 | $12K | Buy |
3,786
+460
| +14% | +$1.46K | ﹤0.01% | 1642 |
|
2022
Q1 | $17K | Buy |
3,326
+516
| +18% | +$2.64K | ﹤0.01% | 1548 |
|
2021
Q4 | $23K | Sell |
2,810
-438
| -13% | -$3.59K | ﹤0.01% | 1373 |
|
2021
Q3 | $32K | Sell |
3,248
-7,175
| -69% | -$70.7K | ﹤0.01% | 1230 |
|
2021
Q2 | $97K | Buy |
10,423
+9,670
| +1,284% | +$90K | ﹤0.01% | 1262 |
|
2021
Q1 | $7K | Sell |
753
-14,524
| -95% | -$135K | ﹤0.01% | 1625 |
|
2020
Q4 | $178K | Sell |
15,277
-32,236
| -68% | -$376K | ﹤0.01% | 845 |
|
2020
Q3 | $532K | Buy |
+47,513
| New | +$532K | ﹤0.01% | 517 |
|